Intermediate Stage of Hepatocellular Carcinoma
1 clinical trials · Condition
◉ Watch Intermediate Stage of Hepatocellular Carcinoma
| Record | Firm | Date |
|---|---|---|
| CTLA-4 /PD-L1 Blockade Following Transarterial Chemoembolization (DEB-TACE) in Patients With Intermediate Stage of HCC (Hepatocellular Carcinoma) Using Durvalumab and Tremelimumab (NCT03638141) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-10-02 |
Track Intermediate Stage of Hepatocellular Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.